Access cutting-edge adhd treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access adhd specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related adhd treatment provided free
This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.
Sponsor: Supernus Pharmaceuticals, Inc.
Check if you qualify for this adhd clinical trial in Little Rock, AR
If you're searching for adhd treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adhd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.